Broughton is focused on the development of innovative scientific programs to deliver quality and regulatory compliance for the companies we work with.
Our team have a successful track record of engagement with both the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK and the Food & Drug Administration (FDA) in the US, on scientific programs for Next Generation Nicotine Delivery Products (NGPs). This includes both the generation of scientific data required for pre-market authorization, and on-going Quality Control (QC) services throughout commercialization.
At the core of our business operations, maintaining an inherent culture of quality is key to our commitment to clients. Regulatory agencies expect manufacturers to be proactive in their efforts towards the development and manufacture of consistently safe products. Our history of quality compliance with global regulatory bodies enables us to add value to the NGP sector throughout their supply chain operations.
Discover our videos, brochures, infographics and much more.
Understand what’s involved in a PMTA and how the recommendations relate to your ENDS business.
Learn more about the process for toxicology risk assessments for ENDS products.
From basic questions to complex compliance inquiries, we're here to help! Contact us today.